Table 1.

Baseline characteristics of the study groups

	IAI monotheraphy	IAI + SMYL combination	P
Mean age±SD (years)	62.64±9.03	63.42±10.14	0.26
Gender
Female	43%	46%	0.94
Male	57%	54%	0.85
Mean DM duration time±SD (years)	18.28±2.24	18.76±2.08	0.67
HbA1c level	8.02±2.43	7.97±2.47	0.66

IAI=Intravitreal aflibercept injection; SMYL=Subthreshold micropulse yellow laser; SD=Standard deviation; DM=Diabetes mellitus